Considerations for controlling invasive meningococcal disease in high income countries

► Safe, effective vaccines are available for the five most common meningococcal serogroups. ► Important for high income countries to determine optimal immunization schedules. ► Data are needed for recombinant MenB vaccines regarding vaccine impact on carriage/herd effects. ► WHO has been reassured by the absence of serious AEFIs following the use of existing OMV vaccines. ► Adequate post-marketing surveillance will be necessary for any broadly protective MenB vaccines.